Susquehanna International Group, LLP Amneal Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $168,204 - $231,346	-26,200 Reduced 35.5%	47,600 $396,000
Q2 2024 Aug 15, 2024	SELL	$5.36 - $7.11 $299,088 - $396,738	-55,800 Reduced 43.06%	73,800 $468,000
Q1 2024 May 07, 2024	SELL	$5.24 - $6.34 $102,704 - $124,264	-19,600 Reduced 13.14%	129,600 $785,000
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $188,832 - $349,002	56,200 Added 60.43%	149,200 $905,000
Q3 2023 Nov 14, 2023	SELL	$2.76 - $4.59 $1,655 - $2,754	-600 Reduced 0.64%	93,000 $392,000
Q2 2023 Aug 11, 2023	BUY	$1.33 - $3.1 $97,356 - $226,920	73,200 Added 358.82%	93,600 $290,000
Q1 2023 May 16, 2023	SELL	$1.27 - $2.7 $7,493 - $15,930	-5,900 Reduced 22.43%	20,400 $28,000
Q4 2022 Feb 14, 2023	SELL	$1.96 - $2.61 $194,628 - $259,173	-99,300 Reduced 79.06%	26,300 $52,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $82,012 - $146,972	40,600 Added 47.76%	125,600 $254,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $88,193 - $130,678	-29,300 Reduced 25.63%	85,000 $270,000
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $299,520 - $375,552	-76,800 Reduced 40.19%	114,300 $477,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $549,050 - $813,150	-139,000 Reduced 42.11%	191,100 $915,000
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $340,058 - $444,996	78,900 Added 31.41%	330,100 $1.76 Million
Q2 2021 Aug 11, 2021	SELL	$5.12 - $6.82 $161,792 - $215,512	-31,600 Reduced 11.17%	251,200 $1.29 Million
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $79,632 - $123,984	16,800 Added 6.32%	282,800 $1.9 Million
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $159,975 - $219,510	-40,500 Reduced 13.21%	266,000 $1.22 Million
Q3 2020 Nov 16, 2020	SELL	$3.54 - $5.27 $48,144 - $71,672	-13,600 Reduced 4.25%	306,500 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$2.87 - $5.46 $824,551 - $1.57 Million	287,300 Added 875.91%	320,100 $1.52 Million
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $13,038 - $28,354	-5,300 Reduced 13.91%	32,800 $114,000
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $177,100 - $392,975	27,500 Added 259.43%	38,100 $273,000
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $318,116 - $397,712	-26,800 Reduced 71.66%	10,600 $150,000
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $489,566 - $803,725	37,400 New	37,400 $506,000

Others Institutions Holding AMRX

# of Institutions

184

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account